Newly Approved Drug Therapies (546): Lamisil/terbinafine Dermgel, 1%, Novartis

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Lamisil/terbinafine Dermgel, 1%

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Novartis
Approval Status: Approved March 1999
Treatment for: Dermatology

General Information

Approval of this over-the-counter formulation provides for use without prescription of Lamisil (terbinafine hydrochloride cream) Cream, 1%, for the treatment of tinea pedis (athlete's foot), tinea cruris (jock itch) and tinea corporis (ringworm), due to Epidermophyton floccosum, Trichophyton mentagrophytes and Trichophyton rubrum.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]